Table 3.
A | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Outcome | ER | PR | Ki67 | HER2 | |||||||||||
positives | % | P | positives | % | P | positives | % | P | positives | % | P | ||||
Clinical response | 0.132 | 0.640 | 0.047 | 0.022 | |||||||||||
Complete response | 3/7 | 43 | 3/7 | 43 | 5/7 | 71 | 8/8 | 100 | |||||||
Partial response | 16/29 | 55 | 11/29 | 38 | 9/27 | 33 | 27/37 | 73 | |||||||
< Partial response | 5/8 | 62 | 2/8 | 25 | 2/8 | 25 | 2/8 | 25 | |||||||
Pathological response | 0.469 | 0.235 | 0.042 | 0.095 | |||||||||||
pCR | 4/7 | 57 | 3/7 | 43 | 5/7 | 71 | 7/8 | 87 | |||||||
<pCR | 20/37 | 54 | 13/37 | 35 | 11/35 | 31 | 30/45 | 67 | |||||||
B | |||||||||||||||
Outcome | cyclinD1 | h-prune | pERK1-2 | p53 | survivin | ||||||||||
positives | % | P | positives | % | P | positives | % | P | positives | % | P | ||||
Clinical response | 0.457 | 0.824 | 0.032 | 0.391 | 0.089 | ||||||||||
Complete response | 1/8 | 12 | 1/8 | 12 | 0/8 | 0 | 1/8 | 12 | 1/8 | 12 | |||||
Partial response | 8/37 | 22 | 5/37 | 14 | 3/37 | 8 | 10/37 | 27 | 15/37 | 41 | |||||
< Partial response | 3/8 | 37 | 2/8 | 25 | 2/8 | 25 | 2/8 | 25 | 5/8 | 62 | |||||
Pathological response | 0.660 | 0.822 | 0.007 | 0.972 | 0.234 | ||||||||||
pCR | 2/8 | 25 | 1/8 | 12 | 0/8 | 0 | 2/8 | 25 | 3/8 | 37 | |||||
<pCR | 10/45 | 22 | 7/45 | 16 | 5/45 | 11 | 11/45 | 24 | 18/45 | 40 |
pCR, pathological complete response